Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies.

Rushlow DE, Mol BM, Kennett JY, Yee S, Pajovic S, Thériault BL, Prigoda-Lee NL, Spencer C, Dimaras H, Corson TW, Pang R, Massey C, Godbout R, Jiang Z, Zacksenhaus E, Paton K, Moll AC, Houdayer C, Raizis A, Halliday W, Lam WL, Boutros PC, Lohmann D, Dorsman JC, Gallie BL.

Lancet Oncol. 2013 Apr;14(4):327-34. doi: 10.1016/S1470-2045(13)70045-7. Epub 2013 Mar 13.

2.

RB1 gene inactivation by chromothripsis in human retinoblastoma.

McEvoy J, Nagahawatte P, Finkelstein D, Richards-Yutz J, Valentine M, Ma J, Mullighan C, Song G, Chen X, Wilson M, Brennan R, Pounds S, Becksfort J, Huether R, Lu C, Fulton RS, Fulton LL, Hong X, Dooling DJ, Ochoa K, Mardis ER, Wilson RK, Easton J, Zhang J, Downing JR, Ganguly A, Dyer MA.

Oncotarget. 2014 Jan 30;5(2):438-50.

3.

Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma.

Dimaras H, Khetan V, Halliday W, Orlic M, Prigoda NL, Piovesan B, Marrano P, Corson TW, Eagle RC Jr, Squire JA, Gallie BL.

Hum Mol Genet. 2008 May 15;17(10):1363-72. doi: 10.1093/hmg/ddn024. Epub 2008 Jan 22.

4.

Loss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progression.

Kooi IE, Mol BM, Moll AC, van der Valk P, de Jong MC, de Graaf P, van Mil SE, Schouten-van Meeteren AY, Meijers-Heijboer H, Kaspers GL, Te Riele H, Cloos J, Dorsman JC.

EBioMedicine. 2015 Jul 8;2(7):660-70. doi: 10.1016/j.ebiom.2015.06.022. eCollection 2015 Jul.

5.

Genomic differences between retinoma and retinoblastoma.

Sampieri K, Mencarelli MA, Epistolato MC, Toti P, Lazzi S, Bruttini M, De Francesco S, Longo I, Meloni I, Mari F, Acquaviva A, Hadjistilianou T, Renieri A, Ariani F.

Acta Oncol. 2008;47(8):1483-92. doi: 10.1080/02841860802342382.

PMID:
18785023
6.

Rb suppresses human cone-precursor-derived retinoblastoma tumours.

Xu XL, Singh HP, Wang L, Qi DL, Poulos BK, Abramson DH, Jhanwar SC, Cobrinik D.

Nature. 2014 Oct 16;514(7522):385-8. doi: 10.1038/nature13813. Epub 2014 Sep 24.

7.

Profiling genomic copy number changes in retinoblastoma beyond loss of RB1.

Bowles E, Corson TW, Bayani J, Squire JA, Wong N, Lai PB, Gallie BL.

Genes Chromosomes Cancer. 2007 Feb;46(2):118-29.

PMID:
17099872
8.

Inactivation of the p53 pathway in retinoblastoma.

Laurie NA, Donovan SL, Shih CS, Zhang J, Mills N, Fuller C, Teunisse A, Lam S, Ramos Y, Mohan A, Johnson D, Wilson M, Rodriguez-Galindo C, Quarto M, Francoz S, Mendrysa SM, Guy RK, Marine JC, Jochemsen AG, Dyer MA.

Nature. 2006 Nov 2;444(7115):61-6.

PMID:
17080083
9.

Molecular karyotype of sporadic unilateral retinoblastoma tumors.

Ganguly A, Nichols KE, Grant G, Rappaport E, Shields C.

Retina. 2009 Jul-Aug;29(7):1002-12. doi: 10.1097/IAE.0b013e3181a0be05.

10.

Unilateral retinoblastoma, lack of familial history and older age does not exclude germline RB1 gene mutation.

Brichard B, Heusterspreute M, De Potter P, Chantrain C, Vermylen C, Sibille C, Gala JL.

Eur J Cancer. 2006 Jan;42(1):65-72.

PMID:
16343894
11.

Changes in MYCN expression in human neuroblastoma cell lines following cisplatin treatment may not be related to MYCN copy numbers.

Prochazka P, Hrabeta J, Vicha A, Cipro S, Stejskalova E, Musil Z, Vodicka P, Eckschlager T.

Oncol Rep. 2013 Jun;29(6):2415-21. doi: 10.3892/or.2013.2383. Epub 2013 Apr 4.

PMID:
23563570
12.

Identification of three new mutations in the RB1 gene in patients with sporadic retinoblastoma in Colombia.

Serrano ML, Yunis JJ.

Biomedica. 2013 Jan-Mar;33(1):53-61. doi: 10.1590/S0120-41572013000100007.

13.

A novel retinoblastoma therapy from genomic and epigenetic analyses.

Zhang J, Benavente CA, McEvoy J, Flores-Otero J, Ding L, Chen X, Ulyanov A, Wu G, Wilson M, Wang J, Brennan R, Rusch M, Manning AL, Ma J, Easton J, Shurtleff S, Mullighan C, Pounds S, Mukatira S, Gupta P, Neale G, Zhao D, Lu C, Fulton RS, Fulton LL, Hong X, Dooling DJ, Ochoa K, Naeve C, Dyson NJ, Mardis ER, Bahrami A, Ellison D, Wilson RK, Downing JR, Dyer MA.

Nature. 2012 Jan 11;481(7381):329-34. doi: 10.1038/nature10733.

14.

Clinical significance of a highly sensitive analysis for gene dosage and the expression level of MYCN in neuroblastoma.

Tanaka S, Tajiri T, Noguchi S, Shono K, Ihara K, Hara T, Suita S.

J Pediatr Surg. 2004 Jan;39(1):63-8.

PMID:
14694373
15.

High resolution SNP array profiling identifies variability in retinoblastoma genome stability.

Mol BM, Massink MP, van der Hout AH, Dommering CJ, Zaman JM, Bosscha MI, Kors WA, Meijers-Heijboer HE, Kaspers GJ, Riele Ht, Moll AC, Cloos J, Dorsman JC.

Genes Chromosomes Cancer. 2014 Jan;53(1):1-14. doi: 10.1002/gcc.22111. Epub 2013 Nov 5.

PMID:
24249257
16.

A Rapid and Sensitive Next-Generation Sequencing Method to Detect RB1 Mutations Improves Care for Retinoblastoma Patients and Their Families.

Li WL, Buckley J, Sanchez-Lara PA, Maglinte DT, Viduetsky L, Tatarinova TV, Aparicio JG, Kim JW, Au M, Ostrow D, Lee TC, O'Gorman M, Judkins A, Cobrinik D, Triche TJ.

J Mol Diagn. 2016 Jul;18(4):480-93. doi: 10.1016/j.jmoldx.2016.02.006. Epub 2016 May 4.

PMID:
27155049
17.

How does MYCN amplification make neuroblastomas behave aggressively? Still more questions than answers.

Maris JM.

Pediatr Blood Cancer. 2005 Dec;45(7):869-70. No abstract available.

PMID:
16206200
18.

Using RB1 mutations to assess minimal residual disease in metastatic retinoblastoma.

Dimaras H, Rushlow D, Halliday W, Doyle JJ, Babyn P, Abella EM, Williams J, Héon E, Gallie BL, Chan HS.

Transl Res. 2010 Aug;156(2):91-7. doi: 10.1016/j.trsl.2010.05.009. Epub 2010 Jun 25.

PMID:
20627193
19.

ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.

Wang Q, Hii G, Shusterman S, Mosse Y, Winter CL, Guo C, Zhao H, Rappaport E, Hogarty MD, Maris JM.

Cancer Res. 2003 Apr 1;63(7):1631-5.

20.

Mutation spectrum of RB1 gene in unilateral retinoblastoma cases from Tunisia and correlations with clinical features.

Ayari-Jeridi H, Moran K, Chebbi A, Bouguila H, Abbes I, Charradi K, Benammar-Elgaaïed A, Ganguly A.

PLoS One. 2015 Jan 20;10(1):e0116615. doi: 10.1371/journal.pone.0116615. eCollection 2015.

Items per page

Supplemental Content

Write to the Help Desk